{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:10:45Z","timestamp":1793185845241,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20354"],"award-info":[{"award-number":["U22A20354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2406903"],"award-info":[{"award-number":["2022YFC2406903"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.nicl.2025.103740","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T07:23:53Z","timestamp":1737962633000},"page":"103740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neurotransmitter imbalance, glutathione depletion and concomitant susceptibility increase in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Su","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingfang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6252-9450","authenticated-orcid":false,"given":"Wenzhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2025.103740_b0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.nicl.2025.103740_b0010","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/aje\/kwad082","article-title":"Metal exposure and risk of parkinson disease: a systematic review and meta-analysis","volume":"192","author":"Zhao","year":"2023","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.nicl.2025.103740_b0015","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12272-019-01196-z","article-title":"The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"issue":"Suppl 6","key":"10.1016\/j.nicl.2025.103740_b0020","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10696","article-title":"GABA, gamma-hydroxybutyric acid, and neurological disease","volume":"54","author":"Wong","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2025.103740_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2015.09.019","article-title":"Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases","volume":"1638","author":"Shetty","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.nicl.2025.103740_b0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nicl.2025.103740_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110716","article-title":"Inhibitory co-transmission from midbrain dopamine neurons relies on presynaptic GABA uptake","volume":"39","author":"Melani","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.nicl.2025.103740_b0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fnmol.2019.00237","article-title":"Voltage-gated calcium channels and \u03b1-synuclein: implications in parkinson's disease","volume":"12","author":"Leandrou","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nicl.2025.103740_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110717","article-title":"Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification","volume":"199","author":"Bj\u00f8rklund","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.nicl.2025.103740_b0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0006-8993(96)00915-8","article-title":"A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome","volume":"741","author":"Gerlach","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.nicl.2025.103740_b0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuroscience.2011.04.010","article-title":"Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis","volume":"191","author":"Luchetti","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nicl.2025.103740_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.880407","article-title":"In vivo illustration of altered dopaminergic and GABAergic systems in early parkinson's disease","volume":"13","author":"Takashima","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nicl.2025.103740_b0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J","article-title":"Simultaneous in vivo spectral editing and water suppression","volume":"11","author":"Mescher","year":"1998","journal-title":"NMR Biomed."},{"key":"10.1016\/j.nicl.2025.103740_b0070","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11910-022-01245-z","article-title":"Molecular imaging of the GABAergic system in parkinson's disease and atypical parkinsonisms","volume":"22","author":"Terkelsen","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nicl.2025.103740_b0075","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/0929867013372995","article-title":"Parkinson's disease\u2013redox mechanisms","volume":"8","author":"Adams","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nicl.2025.103740_b0080","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.nicl.2025.103740_b0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3181\/00379727-190-42879","article-title":"The effect of aging on glutathione and cysteine levels in different regions of the mouse brain","volume":"190","author":"Chen","year":"1989","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.nicl.2025.103740_b0090","doi-asserted-by":"crossref","first-page":"26096","DOI":"10.1074\/jbc.M000120200","article-title":"Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease","volume":"275","author":"Jha","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nicl.2025.103740_b0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.0022-3042.2001.00009.x","article-title":"Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease?","volume":"80","author":"Jha","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nicl.2025.103740_b0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/0470868694.ch3","article-title":"Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?","volume":"235","author":"Andersen","year":"2001","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.nicl.2025.103740_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2024.120632","article-title":"Brain extended and closed forms glutathione levels decrease with age and extended glutathione is associated with visuospatial memory","volume":"293","author":"Hu","year":"2024","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2025.103740_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30521","article-title":"Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: a systematic review","volume":"10","author":"Abbaspour","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.nicl.2025.103740_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.838230","article-title":"Proton magnetic resonance spectroscopy for the early diagnosis of parkinson disease in the substantia nigra and globus pallidus: a meta-analysis with trial sequential analysis","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nicl.2025.103740_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.594711","article-title":"Proton magnetic resonance spectroscopy for diagnosis of non-motor symptoms in parkinson's disease","volume":"13","author":"Guan","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nicl.2025.103740_b0125","doi-asserted-by":"crossref","first-page":"14241","DOI":"10.1038\/s41598-023-41569-5","article-title":"A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson's disease or Alzheimer's disease","volume":"13","author":"Huang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nicl.2025.103740_b0130","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2025.103740_b0135","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209483","article-title":"Regional burden of enlarged perivascular spaces and cognition and neuropsychiatric symptoms in drug-naive patients with parkinson disease","volume":"102","author":"Kim","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2025.103740_b0140","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/jmri.24478","article-title":"Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid\u2013edited MR spectroscopy spectra","volume":"40","author":"Edden","year":"2014","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2025.103740_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm1971","article-title":"Mapping microstructural gradients of the human striatum in normal aging and Parkinson's disease","volume":"8","author":"Drori","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.nicl.2025.103740_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111030","article-title":"Free water and iron content in the substantia nigra at different stages of Parkinson's disease","volume":"167","author":"Chen","year":"2023","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.nicl.2025.103740_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4257","article-title":"Preprocessing, analysis and quantification in single-voxel magnetic resonance spectroscopy: experts' consensus recommendations","volume":"34","author":"Near","year":"2021","journal-title":"NMR Biomed."},{"key":"10.1016\/j.nicl.2025.103740_b0160","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jmri.24903","article-title":"Tissue correction for GABA-edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations","volume":"42","author":"Harris","year":"2015","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2025.103740_b0165","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/mrm.30006","article-title":"Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: a consensus of the ISMRM electro-magnetic tissue properties study group","volume":"91","author":"Bilgic","year":"2024","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.nicl.2025.103740_b0170","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/mrm.26946","article-title":"MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping","volume":"79","author":"Liu","year":"2018","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.nicl.2025.103740_b0175","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1006\/nimg.2002.1092","article-title":"New robust 3-D phase unwrapping algorithms: application to magnetic field mapping and undistorting echoplanar images","volume":"16","author":"Cusack","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2025.103740_b0180","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.neuroimage.2011.08.082","article-title":"Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map","volume":"59","author":"Liu","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2025.103740_b0185","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuroimage.2018.01.008","article-title":"Longitudinal atlas for normative human brain development and aging over the lifespan using quantitative susceptibility mapping","volume":"171","author":"Zhang","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2025.103740_b0190","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10334-021-00910-7","article-title":"Upper brainstem GABA levels in Parkinson's disease","volume":"34","author":"Song","year":"2021","journal-title":"MAGMA"},{"key":"10.1016\/j.nicl.2025.103740_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117309","article-title":"Single-dose L-dopa increases upper brainstem GABA in Parkinson's disease: a preliminary study","volume":"422","author":"Song","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nicl.2025.103740_b0200","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1021\/acschemneuro.3c00717","article-title":"Glutathione depletion and concomitant elevation of susceptibility in patients with parkinson's disease: state-of-the-art MR spectroscopy and neuropsychological study","volume":"14","author":"Shukla","year":"2023","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.nicl.2025.103740_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3686","article-title":"Neurometabolic profiles of the substantia nigra and striatum of MPTP-intoxicated common marmosets: an in vivo proton MRS study at 9.4T","volume":"30","author":"Heo","year":"2017","journal-title":"NMR Biomed."},{"key":"10.1016\/j.nicl.2025.103740_b0210","article-title":"Tiagabine protects dopaminergic neurons against neurotoxins by inhibiting microglial activation","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nicl.2025.103740_b0215","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neuron.2016.04.040","article-title":"Enhanced GABA transmission drives bradykinesia following loss of dopamine D2 receptor signaling","volume":"90","author":"Lemos","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nicl.2025.103740_b0220","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41467-018-03802-y","article-title":"GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease","volume":"9","author":"Lozovaya","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nicl.2025.103740_b0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2013.04.020","article-title":"Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation","volume":"331","author":"Kuruvilla","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nicl.2025.103740_b0230","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/nbm.1141","article-title":"Glutamate measurement in Parkinson's disease using MRS at 3 T field strength","volume":"20","author":"Kickler","year":"2007","journal-title":"NMR Biomed."},{"key":"10.1016\/j.nicl.2025.103740_b0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jon.12074","article-title":"Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease","volume":"25","author":"Weiduschat","year":"2015","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.nicl.2025.103740_b0240","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mrm.20761","article-title":"Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations","volume":"55","author":"\u00d6z","year":"2006","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.nicl.2025.103740_b0245","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2009.08.021","article-title":"Brainstem pathology and non-motor symptoms in PD","volume":"289","author":"Grinberg","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nicl.2025.103740_b0250","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hbm.24857","article-title":"GABAergic changes in the thalamocortical circuit in Parkinson's disease","volume":"41","author":"van Nuland","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nicl.2025.103740_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020096","article-title":"Impairment of motor function correlates with neurometabolite and brain iron alterations in parkinson's disease","volume":"8","author":"Pesch","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.nicl.2025.103740_b0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00415-020-10353-0","article-title":"A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials","volume":"269","author":"Gilat","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.nicl.2025.103740_b0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.smrv.2008.11.003","article-title":"The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases","volume":"13","author":"Iranzo","year":"2009","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.nicl.2025.103740_b0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clineuro.2016.07.002","article-title":"Metabolic abnormality of pontine tegmentum in patients with REM sleep behavior disorder analyzed using magnetic resonance spectroscopy","volume":"148","author":"Zhang","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.nicl.2025.103740_b0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nicl.2025.103740_b0280","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9409363","article-title":"Glutathione as a biomarker in parkinson's disease: associations with aging and disease severity","volume":"2016","author":"Mischley","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.nicl.2025.103740_b0285","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00213-023-06382-y","article-title":"L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson's disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters","volume":"240","author":"Kumar","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nicl.2025.103740_b0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0349-x","article-title":"Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway","volume":"15","author":"Park","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nicl.2025.103740_b0295","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2202-11-144","article-title":"Protein aggregation containing \u03b2-amyloid, \u03b1-synuclein and hyperphosphorylated \u03c4 in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure","volume":"11","author":"Chaves","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nicl.2025.103740_b0300","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.biopsych.2015.04.005","article-title":"Brain glutathione levels\u2013a novel biomarker for mild cognitive impairment and Alzheimer's disease","volume":"78","author":"Mandal","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nicl.2025.103740_b0305","article-title":"GABAergic imbalance in Parkinson\u2019s disease\u2013related depression determined with MEGA-PRESS","volume":"43","author":"Liu","year":"2024","journal-title":"NeuroImage: Clinical"},{"key":"10.1016\/j.nicl.2025.103740_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2024.120547","article-title":"Neuroimaging of Parkinson's disease by quantitative susceptibility mapping","volume":"289","author":"Guan","year":"2024","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2025.103740_b0315","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mds.27776","article-title":"Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease","volume":"34","author":"Vila","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2025.103740_b0320","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nicl.2025.103740_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103503","article-title":"Changes in levels of the antioxidant glutathione in brain and blood across the age span of healthy adults: a systematic review","volume":"40","author":"Detcheverry","year":"2023","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.nicl.2025.103740_b0330","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s11064-020-03030-1","article-title":"Glutathione in brain: overview of its conformations, functions, biochemical characteristics, quantitation and potential therapeutic role in brain disorders","volume":"45","author":"Dwivedi","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nicl.2025.103740_b0335","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neubiorev.2020.10.004","article-title":"The glutathione system in Parkinson\u2019s disease and its progression","volume":"120","author":"Bj\u00f8rklund","year":"2021","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158225000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158225000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T06:17:31Z","timestamp":1752733051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158225000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":67,"alternative-id":["S2213158225000105"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2025.103740","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurotransmitter imbalance, glutathione depletion and concomitant susceptibility increase in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2025.103740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103740"}}